EMA’s Feedback after 2 years of PRIME Procedure

The PRIME Procedure  is a scheme launched by the European Medicines Agency (EMA) to enhance support for the development of medicines that target an unmet medical need.

You wil find enclosed the report that has been published on the EMA website to present the results from the first two years of PRIME.

The report explains how the criteria for eligibility to the scheme have been applied and what type of support applicants have received so far.